Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Systemic scleroderma

Recruiting

Registered drug

Phase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Nemolizumab

Contact Research Centre

Colitis ulcerative

Recruiting

Investigational

Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:SPY002

Contact Research Centre

Non-small cell lung cancer stage I

Recruiting

Investigational

A Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer

Investigational

France

Participants:18–64 years · 65+ years
Substances:Mrna-4157

Contact Research Centre

Alopecia areata

Recruiting

Investigational

A Phase 2a Study of ly4005130 in Adults with Severe Alopecia Areata

Investigational

The Netherlands

Participants:18–64 years

Contact Research Centre

Small cell lung cancer

Recruiting

Registered drugNo placebo

Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Topotecan Hydrochloride

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

Investigational

Study of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)

Investigational

Bulgaria

Participants:18–64 years · 65+ years

Contact Research Centre

Narcolepsy

Recruiting

Investigational

Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Alks 2680

Contact Research Centre

Amyotrophic lateral sclerosis

Recruiting

Investigational

Safety Study of NB-4746 with Riluzole and Placebo in Adults with Amyotrophic Lateral Sclerosis (ALS)

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Riluzole

Contact Research Centre

Narcolepsy

Recruiting

Investigational

Phase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Alks 2680

Contact Research Centre

Systemic lupus erythematosus

Recruiting

Registered drugNo placebo

Evaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Anifrolumab

Contact Research Centre

Asthma

Recruiting

Registered drug

Efficacy and safety of indacaterol acetate (combined with glycopyrronium bromide and mometasone furoate) versus salmeterol/fluticasone in adolescents with asthma

Registered drug

France

Participants:0–17 years
Substances:Indacaterol Acetate

Contact Research Centre

Vitiligo

Recruiting

Investigational

Efficacy and Safety of LY4005130 Compared with Placebo in Adults with Non‑Segmental Vitiligo

Investigational

Belgium

Participants:18–64 years · 65+ years

Contact Research Centre

Find therapies in clinical trials near you – page 2

10 246 trials match your criteria

Systemic scleroderma

Phase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis

Colitis ulcerative

Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

Non-small cell lung cancer stage I

A Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer

Alopecia areata

A Phase 2a Study of ly4005130 in Adults with Severe Alopecia Areata

Small cell lung cancer

Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer

Chronic obstructive pulmonary disease

Study of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)

Narcolepsy

Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2

Amyotrophic lateral sclerosis

Safety Study of NB-4746 with Riluzole and Placebo in Adults with Amyotrophic Lateral Sclerosis (ALS)

Narcolepsy

Phase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1

Systemic lupus erythematosus

Evaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus

Asthma

Efficacy and safety of indacaterol acetate (combined with glycopyrronium bromide and mometasone furoate) versus salmeterol/fluticasone in adolescents with asthma

Vitiligo

Efficacy and Safety of LY4005130 Compared with Placebo in Adults with Non‑Segmental Vitiligo

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.